Repeated implantation of skeletal myoblast in a swine model of chronic myocardial infarction

European Heart Journal

Volumn 31, Issue 8, 2010, Pages 1013-1021

  Gavira, Juan José ^a   Nasarre, Emilio ^a   Abizanda, Gloria ^b   Pérez Ilzarbe, Maitane ^b   De Martino Rodriguez, Alba ^c   García De Jalón, José A ^c   Mazo, Manuel ^b   MacIas, Alfonso ^a   García Bolao, Ignacio ^a   Pelacho, Beatriz ^b   Martínez Caro, Diego ^a   Prósper, Felipe ^b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c UNIVERSIDAD DE ZARAGOZA   (Spain)

Author keywords

Animal model; Myoblast; Myocardial infarction; Stem cells; Swine

Indexed keywords

ANGIOGENESIS; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LABELING; CELL TRANSPLANTATION; CHRONIC DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; ENGRAFTMENT; FIBROSIS; GENERAL ANESTHESIA; HEART ARRHYTHMIA; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FUNCTION; IMMUNOHISTOCHEMISTRY; INJECTION; MINIPIG; MUSCLE BIOPSY; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANIMALS; ARRHYTHMIAS, CARDIAC; CELL DIFFERENTIATION; CHRONIC DISEASE; FIBROSIS; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; MYOBLASTS, SKELETAL; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; SWINE; SWINE, MINIATURE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 77951101705     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp342     Document Type: Article

References (45)

1. Marelli D, Desrosiers C, el-Alfy M, Kao RL, Chiu RC. Cell transplantation for myocardial repair: an experimental approach. Cell Transplant 1992;1:383-390.
2. Menasche P. Skeletal myoblasts and cardiac repair. J Mol Cell Cardiol 2008;45: 545-553.
3. Reinecke H, Poppa V, Murry CE. Skeletal muscle stem cells do not transdifferenti-ate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 2002;34:241-249.
4. Suzuki K, Murtuza B, Beauchamp JR, Smolenski RT, Varela-Carver A, Fukushima S, Coppen SR, Partridge TA, Yacoub MH. Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J 2004;18:1153-1155. (Pubitemid 39561554)
5. Menasche P. Skeletal muscle satellite cell transplantation. Cardiovasc Res 2003;58: 351-357. (Pubitemid 36570393)
6. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD, Kraus WE. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998;4:929-933. (Pubitemid 28364032)
7. Murry CE, Wiseman RW, Schwartz SM, Hauschka SD. Skeletal myoblast trans-plantation for repair of myocardial necrosis. J Clin Invest 1996;98:2512-2523.
8. Suzuki K, Murtuza B, Suzuki N, Smolenski RT, Yacoub MH. Intracoronary infusion of skeletal myoblasts improves cardiac function in doxorubicin-induced heart failure. Circulation 2001;104(Suppl. 12 1):I213-I217.
9. Pouzet B, Vilquin JT, Hagege AA, Scorsin M, Messas E, Fiszman M, Schwartz K, Menasche P. Factors affecting functional outcome after autologous skeletal myo-blast transplantation. Ann Thorac Surg 2001;71:844-850. (discussion 850-841).
10. Menasche P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, Vilquin JT, Marolleau JP, Seymour B, Larghero J, Lake S, Chatellier G, Solomon S, Desnos M, Hagege AA. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008;117:1189-1200. (Pubitemid 351552018)
11. Perez-Ilzarbe M, Agbulut O, Pelacho B, Ciorba C, San Jose-Eneriz E, Desnos M, Hagege AA, Aranda P, Andreu EJ, Menasche P, Prosper F. Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myo-cardium. Eur J Heart Fail 2008;10:1065-1072.
12. Veltman CE, Soliman OI, Geleijnse ML, Vletter WB, Smits PC, ten Cate FJ, Jordaens LJ, Balk AH, Serruys PW, Boersma E, van Domburg RT, van der Giessen WJ. Four-year follow-up of treatment with intramyocardial skeletal myo-blasts injection in patients with ischaemic cardiomyopathy. Eur Heart J 2008;29: 1386-1396.
13. Smits PC, van Geuns RJ, Poldermans D, Bountioukos M, Onderwater EE, Lee CH, Maat AP, Serruys PW. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experi-ence with six-month follow-up. J Am Coll Cardiol 2003;42:2063-2069. (Pubitemid 37549885)
14. Gavira JJ, Herreros J, Perez A, Garcia-Velloso MJ, Barba J, Martin-Herrero F, Canizo C, Martin-Arnau A, Marti-Climent JM, Hernandez M, Lopez-Holgado N, Gonzalez-Santos JM, Martin-Luengo C, Alegria E, Prosper F. Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up. J Thorac Cardiovasc Surg 2006;131:799-804.
15. Menasche P, Hagege AA, Scorsin M, Pouzet B, Desnos M, Duboc D, Schwartz K, Vilquin JT, Marolleau JP. Myoblast transplantation for heart failure. Lancet 2001; 357:279-280. (Pubitemid 32120862)
16. Menasche P, Hagege AA, Vilquin J-T, Desnos M, Abergel E, Pouzet B, Bel A, Sarateanu S, Scorsin M, Schwartz K. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003;41: 1078-1083. (Pubitemid 36384891)
17. Gavira JJ, Perez-Ilzarbe M, Abizanda G, Garcia-Rodriguez A, Orbe J, Paramo JA, Belzunce M, Rabago G, Barba J, Herreros J, Panizo A, de Jalon JA, Martinez-Caro D, Prosper F. A comparison between percutaneous and surgical transplantation of autologous skeletal myoblasts in a swine model of chronic myo-cardial infarction. Cardiovasc Res 2006;71:744-753. (Pubitemid 44848012)
18. Orbe J, Rodriguez JA, Calvo A, Grau A, Belzunce MS, Martinez-Caro D, Paramo JA. Vitamins C and E attenuate plasminogen activator inhibitor-1 (PAI-1) expression in a hypercholesterolemic porcine model of angioplasty. Cardiovasc Res 2001;49:484-492. (Pubitemid 32119566)
19. Herreros J, Prosper F, Perez A, Gavira JJ, Garcia-Velloso MJ, Barba J, Sanchez PL, Canizo C, Rabago G, Marti Climent JM, Hernandez M, Lopez-Holgado N, Gonzalez-Santos JM, Martin-Luengo C, Alegria E. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 2003;24:2012-2020. (Pubitemid 37420448)
20. Meller J, Herman MV, Teichholz LE. Noninvasive assessment of left ventricular function. Adv Intern Med 1979;24:331-357.
21. Suzuki K, Smolenski RT, Jayakumar J, Murtuza B, Brand NJ, Yacoub MH. Heat shock treatment enhances graft cell survival in skeletal myoblast transplantation to the heart. Circulation 2000;102(Suppl. 19 3):III216-III221.
22. Leri A, Kajstura J, Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 2005;85:1373-1416. (Pubitemid 41362274)
23. Ghostine S, Carrion C, Souza LC, Richard P, Bruneval P, Vilquin JT, Pouzet B, Schwartz K, Menasche P, Hagege AA. Long-term efficacy of myoblast transplan-tation on regional structure and function after myocardial infarction. Circulation 2002;106(Suppl. 12 1):I131-I136.
24. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature 2008;451: 937-942.
25. Passier R, van Laake LW, Mummery CL. Stem-cell-based therapy and lessons from the heart. Nature 2008;453:322-329. (Pubitemid 351693138)
26. Rajnoch C, Chachques JC, Berrebi A, Bruneval P, Benoit MO, Carpentier A. Cel-lular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg 2001;121: 871-878. (Pubitemid 33733621)
27. Horackova M, Arora R, Chen R, Armour JA, Cattini PA, Livingston R, Byczko Z. Cell transplantation for treatment of acute myocardial infarction: unique capacity for repair by skeletal muscle satellite cells. Am J Physiol Heart Circ Physiol 2004;287: H1599-H1608.
28. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008;103:1204-1219.
29. Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, Mu H, Melo LG, Pratt RE, Ingwall JS, Dzau VJ. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006;20:661-669. (Pubitemid 44933310)
30. Alfaro MP, Pagni M, Vincent A, Atkinson J, Hill MF, Cates J, Davidson JM, Rottman J, Lee E, Young PP. The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair. Proc Natl Acad Sci USA 2008;105:18366-18371.
31. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, O'Sullivan C, Collins L, Chen Y, Minami E, Gill EA, Ueno S, Yuan C, Gold J, Murry CE. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007;25:1015-1024. (Pubitemid 47517637)
32. Premaratne GU, Tambara K, Fujita M, Lin X, Kanemitsu N, Tomita S, Sakaguchi G, Nakajima H, Ikeda T, Komeda M. Repeated implantation is a more effective cell delivery method in skeletal myoblast transplantation for rat myocardial infarction. Circ J 2006;70:1184-1189. (Pubitemid 44387002)
33. Abraham MR, Henrikson CA, Tung L, Chang MG, Aon M, Xue T, Li RA, O' Rourke B, Marban E. Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ Res 2005;97:159-167. (Pubitemid 41033472)
34. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:141-148. (Pubitemid 38891685)
35. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, Hecker H, Schaefer A, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006;113:1287-1294. (Pubitemid 43739450)
36. Li TS, Mikamo A, Takahashi M, Suzuki R, Ueda K, Ikeda Y, Matsuzaki M, Hamano K. Comparison of cell therapy and cytokine therapy for functional repair in ischemic and nonischemic heart failure. Cell Transplant 2007;16:365-374.
37. Tse HF, Siu CW, Zhu SG, Songyan L, Zhang QY, Lai WH, Kwong YL, Nicholls J, Lau CP. Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. Eur J Heart Fail 2007;9:747-753. (Pubitemid 47212824)
38. Misao Y, Takemura G, Arai M, Sato S, Suzuki K, Miyata S, Kosai K, Minatoguchi S, Fujiwara T, Fujiwara H. Bone marrow-derived myocyte-like cells and regulation of repair-related cytokines after bone marrow cell transplantation. Cardiovasc Res 2006;69:476-490. (Pubitemid 43098804)
39. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, Epstein SE. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004;94:678-685. (Pubitemid 38387752)
40. Murtuza B, Suzuki K, Bou-Gharios G, Beauchamp JR, Smolenski RT, Partridge TA, Yacoub MH. Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc Natl Acad Sci USA 2004;101:4216-4221. (Pubitemid 38405909)
41. Winitsky SO, Gopal TV, Hassanzadeh S, Takahashi H, Gryder D, Rogawski MA, Takeda K, Yu ZX, Xu YH, Epstein ND. Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro. PLoS Biol 2005; 3:e87.
42. Qu-Petersen Z, Deasy B, Jankowski R, Ikezawa M, Cummins J, Pruchnic R, Mytinger J, Cao B, Gates C, Wernig A, Huard J. Identification of a novel popu-lation of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 2002;157:851-864. (Pubitemid 34847822)
43. Oshima H, Payne TR, Urish KL, Sakai T, Ling Y, Gharaibeh B, Tobita K, Keller BB, Cummins JH, Huard J. Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther 2005;12:1130-1141. (Pubitemid 41723047)
44. Okada M, Payne TR, Zheng B, Oshima H, Momoi N, Tobita K, Keller BB, Phillippi JA, Peault B, Huard J. Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myo-cardium. J Am Coll Cardiol 2008;52:1869-1880.
45. Abraham MR, Hare JM. Is skeletal myoblast transplantation proarrhythmic? The jury is still out. Heart Rhythm 2006;3:462-463.